Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A | P29274 | 1/20 | 0.36 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.36 |
| ▸ | NPEPPS | P55786 | 8/20 | 0.36 |
| ▸ | ANPEP | P15144 | 8/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.34 |
| ▸ | TP53 | P04637 | 2/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28344455 | 1.00 | ADORA2A (0.36) | ADORA2AADORA2BNPEPPSANPEPSMN1; SMN2 | |
| SCHEMBL26981136 | 0.87 | ADORA2A (0.38) | ADORA2AADORA2BNPEPPSANPEPSMN1; SMN2 | |
| SCHEMBL29835052 | 0.87 | ADORA2A (0.38) | ADORA2AADORA2BNPEPPSANPEPSMN1; SMN2 | |
| SCHEMBL28521252 | 0.86 | HTR2C (0.31) | — | |
| SCHEMBL31192291 | 0.86 | HTR2C (0.31) | — | |
| SCHEMBL31228871 | 0.84 | NPEPPS (0.35) | ADORA2AADORA2BNPEPPSANPEPSMN1; SMN2 | |
| SCHEMBL28758954 | 0.83 | SLC29A1 (0.37) | ADORA2AADORA2BNPEPPSANPEP | |
| SCHEMBL30042226 | 0.78 | PI4KA (0.39) | ADORA2AADORA2BSMN1; SMN2TP53LMNA | |
| SCHEMBL2463541 | 0.78 | ADORA3 (0.50) | ADORA2AADORA2BSMN1; SMN2 | |
| SCHEMBL16987222 | 0.78 | TARS1 (0.38) | TP53LMNAHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122029278-A | Constructs, methods and uses for the preparation of circular RNAs | 上海环码生物医药有限公司 | 2026-05-12 | — | — | CN | disclosed |
| CN-120092091-A | Synthetic circular RNA compositions and methods of use thereof | 上海环码生物医药有限公司 | 2025-06-03 | — | — | CN | disclosed |
| CN-119947747-A | Influenza virus vaccine | 葛兰素史克生物有限公司 | 2025-05-06 | — | — | CN | disclosed |
| CN-119768532-A | Method for producing nucleic acid | 辉瑞公司 | 2025-04-04 | — | — | CN | disclosed |
| CN-119233964-A | Single component delivery system for nucleic acids | 宾夕法尼亚大学理事会 | 2024-12-31 | — | — | CN | disclosed |